• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

hepatocellular carcinoma (HCC) - Articles and news items

BTG receives CE mark certification for radiopaque drug-eluting bead

Industry news / 6 April 2017 / Niamh Marriott, Junior Editor

BTG has received Class III CE Mark certification for DC Bead LUMI, the first commercially available radiopaque drug-eluting bead…

FDA grants priority review for Bayer’s liver cancer treatment

Industry news / 4 January 2017 / Niamh Louise Marriott, Digital Editor

The application is based on data from the placebo-controlled Phase III trial which investigated the drug as a second line treatment…

RedHill Biopharma commences Phase II hepatocellular carcinoma study

Industry news / 5 October 2016 / Niamh Louise Marriott, Digital Content Producer

RedHill Biopharma, will shortly commence a study evaluating yeliva (ABC294640) in patients with advanced hepatocellular carcinoma (HCC), pending final…

Regorafenib increases overall survival in hepatocellular carcinoma study

Industry news / 29 June 2016 / Victoria White, Digital Content Producer

Results from the Phase III RESORCE trial investigating Bayer’s regorafenib in patients with unresectable hepatocellular carcinoma have been announced…